Department of Surgery, University Medical Center Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, 23564, Lübeck, Germany.
Network for Care, Quality and Research in Oncology (ADT), German Cancer Registry Group of the Society of German Tumor Centers, Berlin, Germany.
J Cancer Res Clin Oncol. 2023 Sep;149(11):8535-8543. doi: 10.1007/s00432-023-04785-0. Epub 2023 Apr 24.
The available literature regarding outcome after pancreatic resection in locally advanced non-functional pNEN (LA-pNEN) is sparse. Therefore, this study evaluates the current survival outcomes and prognostic factors in after resection of LA-pNEN.
This population-based analysis was derived from 17 German cancer registries from 2000 to 2019. Patients with upfront resected non-functional non-metastatic LA-pNEN were included.
Out of 2776 patients with pNEN, 277 met the inclusion criteria. 137 (45%) of the patients were female. The median age was 63 ± 18 years. Lymph node metastasis was present in 45%. G1, G2 and G3 pNEN were found in 39%, 47% and 14% of the patients, respectively. Resection of LA-pNEN resulted in favorable 3-, 5- and 10-year overall survival of 79%, 74%, and 47%. Positive resection margin was the only potentially modifiable independent prognostic factor for overall survival (HR 1.93, 95% CI 1.71-3.69, p value = 0.046), whereas tumor grade G3 (HR 5.26, 95% CI 2.09-13.25, p value < 0.001) and lymphangiosis (HR 2.35, 95% CI 1.20-4.59, p value = 0.012) were the only independent prognostic factors for disease-free survival.
Resection of LA-pNEN is feasible and associated with favorable overall survival. G1 LA-pNEN with negative resection margins and absence of lymph node metastasis and lymphangiosis might be considered as cured, while those not fulfilling these criteria might be considered as a high-risk group for disease progression. Herein, negative resection margins represent the only potentially modifiable prognostic factor in LA-pNEN but seem to be influenced by tumor grade.
关于局部晚期非功能性胰腺神经内分泌肿瘤(LA-pNEN)切除术后的结果,相关文献较少。因此,本研究评估了 LA-pNEN 切除术后的当前生存结果和预后因素。
本基于人群的分析来自 2000 年至 2019 年的 17 个德国癌症登记处。纳入了接受初次切除的非转移性非功能性 LA-pNEN 患者。
在 2776 名 pNEN 患者中,有 277 名符合纳入标准。137 名(45%)患者为女性。中位年龄为 63±18 岁。有 45%的患者存在淋巴结转移。G1、G2 和 G3 pNEN 分别在 39%、47%和 14%的患者中发现。LA-pNEN 的切除导致 3 年、5 年和 10 年的总生存率分别为 79%、74%和 47%。阳性切缘是唯一可能改变的独立总生存预后因素(HR 1.93,95%CI 1.71-3.69,p 值=0.046),而肿瘤分级 G3(HR 5.26,95%CI 2.09-13.25,p 值<0.001)和淋巴管浸润(HR 2.35,95%CI 1.20-4.59,p 值=0.012)是无病生存的唯一独立预后因素。
LA-pNEN 的切除是可行的,与良好的总生存率相关。G1 LA-pNEN 且切缘阴性、无淋巴结转移和淋巴管浸润者可被认为是治愈的,而不符合这些标准的患者可能被认为是疾病进展的高危人群。在此,阴性切缘是 LA-pNEN 中唯一可能改变的预后因素,但似乎受肿瘤分级的影响。